Literature DB >> 6092967

Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord.

I Jurna.   

Abstract

The effect of intrathecal (i.t.) and systemic (i.p. and i.v.) administration of morphine, aminophylline, dibutyryl cyclic adenosine monophosphate (DBcAMP) and dibutyryl cyclic guanosine monophosphate (DBcGMP) on motor and sensory responses of the spinal nociceptive system was studied in rats. Motor responses were assessed in the tail-flick test performed on rats with an intact spinal cord, or as flexor reflex activity elicited in the electromyogram of the tibialis anterior muscle by supramaximal electrical stimulation of the sural nerve in rats in which the spinal cord was transected at the lower thoracic level. The sensory response consisted of activity in single ascending axons of the spinal cord evoked by electrical stimulation of afferent C fibres in spinal rats. Morphine (20 micrograms i.t. or 2 mg/kg i.p.) prolonged the tail-flick latency and aminophylline (25 mg/kg i.p. or 50 micrograms i.t.) prevented the antinociceptive effect of morphine. Aminophylline alone, administered by i.t. injection, reduced the tail-flick latency in a dose-dependent way. Morphine (2 mg/kg i.v. or 10 micrograms i.t.) reduced flexor reflex activity, and this reduction was abolished by aminophylline (25 mg/kg i.v. or 50 micrograms i.t.). Morphine (2 mg/kg i.v.) depressed spontaneous and evoked activity in single ascending axons responding to stimulation of afferent C fibres. This depressant effect of morphine was not abolished by aminophylline (50 micrograms i.t.); the depression was antagonized by naloxone (10 micrograms i.t.). DBcAMP (5 to 100 ng i.t.) dose-dependently prolonged the tail-flick latency. The antinociceptive effect of DBcAMP (50 ng i.t.) was prevented by aminophylline (50 micrograms i.t.) or naloxone (5 micrograms i.t.).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092967     DOI: 10.1007/bf00504987

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Is adenosine the mediator of opiate action on neuronal firing rate?

Authors:  T W Stone; M N Perkins
Journal:  Nature       Date:  1979-09-20       Impact factor: 49.962

2.  Antinociceptive action of the butyryl derivatives of cyclic guanosine 3':5'-monophosphate.

Authors:  F J Vocci; S K Petty; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

3.  Effects of morphine on dopamine-stimulated adenylate cyclase and on cyclic GMP formation in primate brain amygdaloid nucleus.

Authors:  D Wilkening; R K Mishra; M H Makman
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

Review 4.  Cyclic nucleotides and the central effects of opiates: an overview of current research.

Authors:  G C Rosenfeld; S J Strada; G A Robison
Journal:  Adv Biochem Psychopharmacol       Date:  1979

5.  Cyclic adenosine monophosphate antagonism of morphine analgesia.

Authors:  I K Ho; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1973-05       Impact factor: 4.030

6.  An A1-adenosine receptor, characterized by [3H] cyclohexyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation.

Authors:  M Reddington; K S Lee; P Schubert
Journal:  Neurosci Lett       Date:  1982-03-05       Impact factor: 3.046

7.  Aminophylline differentiates between the depressant effects of morphine on the spinal nociceptive reflex and on the spinal ascending activity evoked from afferent C fibres.

Authors:  I Jurna
Journal:  Eur J Pharmacol       Date:  1981-05-22       Impact factor: 4.432

8.  Analgesia mediated by a direct spinal action of narcotics.

Authors:  T L Yaksh; T A Rudy
Journal:  Science       Date:  1976-06-25       Impact factor: 47.728

9.  Effects of intrathecally administered pentobarbital and naloxone on the activity evoked in ascending axons of the rat spinal cord by stimulation of afferent A and C fibres. Further evidence for a tonic endorphinergic inhibition in nociception.

Authors:  G Bernatzky; T Doi; I Jurna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

10.  Cyclic AMP, morphine, met-enkephalin and neuronal firing.

Authors:  D A Hosford; H J Haigler
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

View more
  6 in total

1.  Characterization of the antinociceptive effects of some adenosine analogues in the rat.

Authors:  M Holmgren; J Hedner; T Mellstrand; G Nordberg; T Hedner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

2.  Dibutyryl-cyclic GMP induces peripheral antinociception via activation of ATP-sensitive K(+) channels in the rat PGE2-induced hyperalgesic paw.

Authors:  A C Soares; I D Duarte
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  Classification of adenosine receptors mediating antinociception in the rat spinal cord.

Authors:  J Sawynok; M I Sweeney; T D White
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

4.  Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices.

Authors:  M R Vasko; H Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

5.  Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors.

Authors:  D A Valério; F I Ferreira; T M Cunha; J C Alves-Filho; F O Lima; J R De Oliveira; S H Ferreira; F Q Cunha; R H Queiroz; W A Verri
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

6.  Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord.

Authors:  I Jurna; P Krauss; J Baldauf
Journal:  Clin Investig       Date:  1993-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.